Immunocytokines are those molecules which are prepared by connecting cytokines with monoclonal antibodies (that react to tumor), thereby causing immune cells to get stimulated. These molecules are generally utilized to treat tumors.
The immunocytokines market is fragmented into targeting sites, disease conditions and clinical trials. The worldwide market is also divided on the basis of regions. The regions include North America, Asia Pacific, Europe and the rest of the world.
Many companies in North America and Europe are completing scientific experiments on immunocytokines, furthered by growing cancer cases in these regions. The Asia Pacific region’s pharma firms are also witnessing development in the immunocytokines market.